摘要
心房颤动(Atrial fibrillation,Af)是临床上常见的房性心律失常,随着年龄的增长,其发生率增高。美国自然人群房颤的患病率为0.95%,年龄低于55岁者,房颤的患病率为0.1%,而80岁以上的人群为9.0%,估计到2050年房颤患者的人数将超过560万。通过对资料的分析,Heeringa等计算的55岁发生房颤的终生危险分别为:男性23.8%,女性22.2%。
出处
《中国心血管病研究》
CAS
2007年第7期554-557,共4页
Chinese Journal of Cardiovascular Research
参考文献26
-
1[1]Go AS,Hylek EM,Phillips KA,et al.Prevalence of diagnosed atrial fibrillation in adults,national implications for rhythm management and stroke prevention:the Anticoagulation and Risk Factots in Atrial Fibrillation Study.JAMA,2001,285:2370-2375.
-
2[2]Heeringa J,Vande-Kuip DAM,Hofman A,et al.Prevalence,incidence and lifetime risk of atrial fibrillation:the Rotterdam study.Eur Heart J,2006,27:949-953.
-
3周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1397
-
4[4]Frenette PS,Denis CV,Weiss L,et al.P-selectin glycoprotein ligand-1(PSGL-1)is expressed on platelets and can mediate platelet-endothelial interaction in vivo.J Exp Med,2000,191:1413-1422.
-
5[5]Li L,Qian KX,Gong JG.A 28-Kda glycoprotein functions as a platelet ligand for P-selectin.Thromb Haemost,2002,87:706-711.
-
6[6]Kiefmann R,Heckel K,Schenkat S,et al.Platelet-endothelial cell interaction in pulmonary micro-circulation:the role of PARS.Thromb Haemost,2004,91:761-770.
-
7[7]assberg S,Enders G,Leiderer R,et al.Platelet-endothelial cell interactions during ischemia/reperfusion:the role of P-selectin.Blood,1998,92:507-515.
-
8[8]Khandoga A,Biberthaler P,Enders G,et al.P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo.Shock.2002.18:529-535.
-
9[9]Massberg S,Brand K,Gruner s,et al.A critical zole of platelet adhesion in the initiation of atherosclercic lesion formation.J Exp Med,2002,196:887-896.
-
10[10]Burger PC,Wagner DD.Platelet P-selectin facilitates atherosclerotic lesion development.Blood,2003,101:2661-2666.
二级参考文献10
-
1Giardina EGV. Atrial fibrillation and stoke, elucidating a newly discovered risk factor[J].Am J Cardiol,1997;80(4C):11D-18D
-
2Fatkin D,Keily RP, Foneley MP. Relation between left atrial appendage blood flow velocity,spontaneous echocardiographic contrast and thromboembolic risk in vivo[J].J Am Coll Cardiol,1994;23(4):961~969
-
3Falcone RA,Morady F,Armstrong WF.Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioveversion of atrial fibrillation[J].Am J Cardiol,1996;78(4):435~439
-
4Li YH,Ko L, et al. Left atrial spontaneous echocardiographic ocontrast in patients with rhumatic mitrial valve disease in sinus rhythm: Implication of a altered left atrial appendage function[J]. Chest,1995;108(1):99~103
-
5Jones EF, Calafiore P,McNeil JJ,et al. Atrial fibrillation with left atrial spontaneous echocardiographic contrast detected by transesophageal echocardiography is a potent risk factor for stroke[J].Am J Cardiol,1996;78(4):425~429
-
6Falk RH.Antithrombolic therapy in atriai fibrillation.in Falk RH, Porid PJ,eds. Atrial fibrialltion:mechanisms and management [M].Philadelphia:Lippincotl-Ravent.1997:227~298
-
7Lip GY, Lowe GD, Rumley A, et al. Increased markers of throbogenesis in chronic atrial fibrillation:effects of warfarin treatment[J].Br Heart J;1995;73(6):527~533
-
8Sohara H, Amitari S,Kwrose M,et al. Atrial fibrillation activates platelets and coagulation in time dependent manner: A study in patients with paroxysmal atrial fibrillation[J].J Am Coll Cardiol,1997;29(1):106~112
-
9Lip GY,Lowe GD.Fibrin D-dimer: a useful marker of thrombogenesis[J]?Clin Sci,1995;89(3):205~214
-
10胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:359
共引文献1400
-
1俞娅娅,李小荣,余金波,杨兵.心房颤动综合管理ABC方案[J].中国心脏起搏与心电生理杂志,2020,0(1):7-10. 被引量:10
-
2周睿,王禹川.心房颤动患者的规范化治疗[J].慢性病学杂志,2022(10):1468-1471.
-
3丁小亮.老年非瓣膜性心房颤动经利伐沙班治疗的安全性评价[J].世界最新医学信息文摘,2019,0(81):120-120. 被引量:1
-
4贺毅,李志超,王伟文(综述),廖晓阳(审校).无创筛查阵发性心房颤动研究进展[J].武警医学,2020,0(1):77-81. 被引量:3
-
5夏熠,李道博,王运松,高睿媛,董颖雪,尹晓盟,高连君,夏云龙.中性粒细胞与淋巴细胞比值对非瓣膜病心房颤动患者射频消融围术期抗凝出血风险的预测价值[J].临床心血管病杂志,2020,36(1):55-59. 被引量:9
-
6蔡小娟,陈艳.我国脑卒中流行及防控现状[J].广东医学,2019,40(S01):212-215. 被引量:33
-
7顾智淳,张在丽,刘晓琰.1例胺碘酮致华法林国际标准化比值升高的病例分析[J].医药导报,2015,34(S01):172-173. 被引量:1
-
8冯琳琳,纪文岩.从肝肾论治老年性房颤举隅[J].世界最新医学信息文摘,2020(11):226-227.
-
9桑叶.44例心房纤颤合并长间期临床意义分析[J].医学信息(医学与计算机应用),2014,0(30):254-254.
-
10黄健.抗凝小组在非瓣膜性房颤患者华法林治疗中的应用研究[J].医学信息(医学与计算机应用),2014,0(13):62-62.
同被引文献36
-
1杜爱玲,孙金红.慢性心房颤动患者P-选择素水平及内皮功能障碍[J].医师进修杂志,2005,28(1):30-31. 被引量:3
-
2冯达应,陈晓平.心房颤动与炎症和氧化应激[J].心血管病学进展,2006,27(3):352-355. 被引量:8
-
3孙婷,王秀芳.同型半胱氨酸、高敏C反应蛋白与房颤的关系[J].浙江实用医学,2006,11(3):145-145. 被引量:12
-
4Yeh E T,Anderson H V,Pasceri V,et al.C-reactive Protein:linking inflammation to cardiovascular complications.Circulation,2001,104:992-997.
-
5Kotsakou H,Kartasis Z,Tziakas D,et al.Atrial Fibrillation and Hypercoagulability:dependent on clinical factors or/and on genetic alterations?J Thrombosis Thrombolysis,2003,16:155-161.
-
6Conway D S,Pearce L A,Chin B S,et al.Plasms von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation:relationship to stroke risk factors.Circulation,2002,106:1962-1967.
-
7Bedard P W,Clerin V,Sushkova N,et al.Characterization of the novel P-selectin inhibitor PSI-697[2-(4-chlorobenzyl)-3-hyaroxy-7,8,9,10-tetr-ahydmbenzo[h]quinoline-4-carboxylic acid]in vitro and in rodent models of vascular inflammation and thrombosis.J Phammeol Exp Ther,2008,324:497-506.
-
8Gok F,Ugur Y,Ozen S,et al.Pathogenesis-related adhesion molecules in Henoch-Schonlein vasculitis.Rheumatol Int,2008,28:313-316.
-
9Meyer M F,Sehnfidt O,Hellmich B,et al.Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry:relationship to soluble adhesion molecules and extraarticular anifestations.Rheumatol Int,2007,28:145-152.
-
10李妙龄,曾晓荣.膜片钳技术在心血管及药理学研究中的应用[J].中国心血管病研究,2007,5(9):698-700. 被引量:7
二级引证文献11
-
1金仙珍.阿托伐他汀强化治疗冠心病并发阵发性心房颤动的疗效观察及对血清超敏C反应蛋白的影响[J].中国基层医药,2015,22(6):913-915. 被引量:3
-
2周代星,王照华.丹参酮ⅡA对家兔急性心肌梗死后心肌钙调蛋白依赖性蛋白激酶Ⅱ信号通路及室性心律失常的影响[J].中国心血管病研究,2015,13(4):368-371. 被引量:19
-
3陈雄华.瑞舒伐他汀强化疗法对冠心病并发阵发性心房颤动炎症因子及临床预后的影响[J].海峡药学,2016,28(3):109-110. 被引量:7
-
4卜琳琳,卜彬,黄田.丹参酮对肾血管性高血压患者钙调蛋白依赖性蛋白激酶Ⅱ信号通路及心律失常的影响[J].中国中医急症,2016,25(6):1169-1171. 被引量:10
-
5李小燕,黄萍,陈少秀,彭吉霞.丹参酮ⅡA对心肌梗死模型大鼠心肌钙调蛋白及心功能的影响[J].国际中医中药杂志,2016,38(8):728-732. 被引量:2
-
6流行性乙型脑炎、流行性脑脊髓膜炎、百日咳和白喉等传染病控制情况如何?[J].国际中医中药杂志,2016,38(8):732-732.
-
7杨凤翔,张小乔,罗秀玲.侧脑室注射神经节苷脂钠对脑瘫模型大鼠学习记忆能力的影响[J].实验动物与比较医学,2017,37(1):15-19. 被引量:3
-
8罗秀玲,赵峰,胡睿嫱,陈德森.神经节苷脂钠侧脑室注射对脑性瘫痪模型大鼠学习记忆能力的影响[J].安徽医药,2017,21(1):32-35. 被引量:6
-
9马晓芸,叶远征,居勒德孜·海拉提,马尔加恩·巴克依,刘志强.P-选择素与房颤及房颤合并血栓的Meta分析[J].新疆医科大学学报,2021,44(8):869-876. 被引量:1
-
10苏亚平,卜琳琳,李平平,周利,高毓文,沈睿,卜斌,吴胜英.丹参酮ⅡA注射液对急性心肌梗死大鼠钙调蛋白依赖性蛋白激酶Ⅱ表达及心肌收缩力的影响[J].中国中医急症,2016,25(2):204-207. 被引量:14
-
1石玉茹,唐耀武,贺雄,董振英,吴疆,褚天新.北京市自然人群流行性感冒的流行病学调查[J].中国公共卫生,2000,16(2):149-150. 被引量:8
-
2樊艳华.您的胆结石可以经口腔取吗[J].健康促进,2011(1):21-22.
-
3逯建华,汤迎春.心房颤动的诊断与治疗进展[J].中国现代医药杂志,2011,13(3):134-135. 被引量:1
-
4死亡率与病死率的正确应用[J].消化外科,2006,5(5):320-320.
-
5刘勤俭,王俊雅.广州郊县某镇235例自然人群及市区20个家庭HP感染的调查分析[J].广东医学,1993,14(6):321-323.
-
6洪昭光.悄悄的凶手严峻的挑战(中)[J].药物与人,2001,14(12):4-5.
-
7邵也常,刘小清,吴勇,王丁,戴耀宗,饶栩栩.自然人群中C反应蛋白与冠心病危险因素的关系[J].岭南心血管病杂志,2002,8(4):229-231.
-
8白亚静,吴金花,杨杨.心房颤动与炎症的相关性研究进展[J].心脑血管病防治,2016,16(4):294-296. 被引量:3
-
9胡法国,杨麦广,郝篷.叶酸对急性心肌梗死合并心房颤动患者的疗效观察[J].中国现代药物应用,2014,8(2):26-27. 被引量:1
-
10潘肯林,安效声,柳军.50例老年人心房颤动相关病因分析[J].新疆医科大学学报,2002,25(1):19-19.